Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 691

3.
4.
5.

[CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].

Wang ZS, Wu LQ, Yi X, Geng C, Li YJ, Yao RY, Hu WY, Han B.

Zhonghua Zhong Liu Za Zhi. 2012 Oct;34(10):753-8. doi: 10.3760/cma.j.issn.0253-3766.2012.10.008. Chinese.

PMID:
23291069
6.
7.

Villin 1 is a predictive factor for the recurrence of high serum alpha-fetoprotein-associated hepatocellular carcinoma after hepatectomy.

Xieraili M, Yasen M, Mogushi K, Obulhasim G, Mayinuer A, Aihara A, Tanaka S, Mizushima H, Tanaka H, Arii S.

Cancer Sci. 2012 Aug;103(8):1493-501. doi: 10.1111/j.1349-7006.2012.02315.x. Epub 2012 May 25.

8.

Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.

Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, Hirata K.

World J Gastroenterol. 2015 Apr 28;21(16):4933-45. doi: 10.3748/wjg.v21.i16.4933.

9.

α-fetoprotein, vascular endothelial growth factor receptor-1 and early recurrence of hepatoma.

Kamiyama T, Takahashi M, Nakanishi K, Yokoo H, Kamachi H, Kobayashi N, Ozaki M, Todo S.

World J Gastroenterol. 2012 Jan 28;18(4):340-8. doi: 10.3748/wjg.v18.i4.340.

10.

Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?

Zhang Y, Song T, Meng L, Wu X, Ba Y, Li Q.

ANZ J Surg. 2009 Jan-Feb;79(1-2):62-9. doi: 10.1111/j.1445-2197.2008.04801.x.

PMID:
19183381
11.

[Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].

Shi M, Zhang Y, Zhong C, Lin XJ, Zhang CQ, Li JQ.

Ai Zheng. 2008 Jan;27(1):83-7. Chinese.

PMID:
18184471
12.

Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.

Blank S, Wang Q, Fiel MI, Luan W, Kim KW, Kadri H, Mandeli J, Hiotis SP.

Ann Surg Oncol. 2014 Mar;21(3):986-94.

PMID:
24232510
13.

AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.

Kamiyama T, Takahashi M, Nakagawa T, Nakanishi K, Kamachi H, Suzuki T, Shimamura T, Taniguchi M, Ozaki M, Matsushita M, Furukawa H, Todo S.

Ann Surg. 2006 Sep;244(3):451-63.

14.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
15.

Comparison of AFP-L3 and p53 Antigen Concentration with Alpha-Fetoprotein as Serum Markers for Hepatocellular Carcinoma.

Abdel-Aziz MM, Elshal MF, Abass AT, El-Kafrawy S, Ezzat S, Abdel-Wahab M.

Clin Lab. 2016;62(6):1121-9.

PMID:
27468575
16.
17.
18.

Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?

Jeng KS, Sheen IS, Tsai YC.

Am J Gastroenterol. 2004 Aug;99(8):1503-9.

PMID:
15307868
19.

Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.

Zheng H, Yang Y, Wang MC, Yuan SX, Tian T, Han J, Ni JS, Wang J, Xing H, Zhou WP.

Surg Oncol. 2016 Sep;25(3):171-7. doi: 10.1016/j.suronc.2016.05.026. Epub 2016 May 24.

PMID:
27566019
20.

Supplemental Content

Support Center